Cover Image


Prefilled Syringes to 2022

出版商 Greystone Research Associates 商品編碼 321891
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
預填充式注射器(已填充藥劑之注射器)市場預測 Prefilled Syringes to 2022
出版日期: 2015年01月01日 內容資訊: 英文

注射投藥對許多藥物來說是不可缺的。 由於削減醫療費的管理護理供應商的配合措施,慢性疾病等的藥物自我施打普及,非口服藥物遞輸的使用擴大。由於預填充式注射器(已填充藥劑之注射器)的使用擴大造成對安全性問題的關注高漲,預填充安全性注射器和安全性高的解決方案於市面販售。





  • 供應鏈要素
  • 整合產業
  • 競爭環境
  • 需求促進要素



  • 疾病與適應
  • 患者趨勢
  • 給藥頻率和安全性
  • 管理護理的配合



  • 材料選擇問題
  • 使用點的重組
  • 看護者的安全性
  • 針管理策略
  • 人機學/人體工學


  • 預填治療用注射器
  • 玻璃製預填充式注射器
  • 塑膠製預填充式注射器
  • 可即時填充的注射器
  • 特殊預填充式注射器


  • 過敏性反應
  • 抗凝固劑
  • 自體免疫疾病
  • 急救醫療
  • 肝炎
  • 造血、紅血球生成促進蛋白質
  • 代謝性疾病
  • 神經科
  • 再生醫療
  • 疫苗



  • 法規指引和產品認證
  • PFS生態系統的發展


Product Code: PFJ634K

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Market-driven Product Strategies

A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumer-compatible form of packaging and application.


  • Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics
  • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
  • Examines design factors, material selection issues, technologies and market development issues
  • Provides product data, market share, and forecasts to 2022
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

What You Will Learn

  • What drugs are supplied in prefilled syringes, what are the device specifics, and who markets them?
  • Who are the branded prefilled syringe suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors driving prefilled syringe demand?
  • How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
  • What are the essential design factors, material selection issues, technologies and market development issues for injectable drug products?
  • What are prefilled device categories that compete with prefilled syringes and what is their market share?

Table of Contents

  • Executive Summary
  • The Prefilled Device Landscape
  • Evolving Device Technology
  • Supply Chain Factors
  • Industry Alignment
  • Competitive Landscape
  • Demand Drivers
  • Therapeutic Market Factors
  • Drug Discovery and Development
  • Diseases and Indications
  • Patient Demographics
  • Dosing Frequency and Safety
  • Managed Care Initiatives
  • Prefilled Syringes - Design Factors
  • Drug Stability and Shelf Life
  • Material Selection Issues
  • Point-of-Use Reconstitution
  • Caregiver Safety
  • Needle Configuration Strategies
  • Human Engineering/Ergonomics
  • Prefilled Syringes - Commercial Devices
  • Prefillable Therapeutic Injectables
  • Glass Prefillable Syringes
  • Plastic Prefillable Syringes
  • Ready-to-Fill Safety Syringes
  • Specialty Prefillable Syringes
  • Flush Syringes
  • Diluent Syringes
  • Imaging Agent Syringes
  • Prefilled Syringe Market Segments
  • Anaphylaxis
  • Anticoagulants
  • Autoimmune Diseases
  • Emergency Medicine
  • Hepatitis
  • Hematopoietics and Related Erythropoiesis Stimulating Proteins
  • Metabolic Diseases
  • Neurology
  • Reproductive Health
  • Vaccines
  • Non-API Prefilled Syringe Segments
  • Market Factors
  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • The Evolving PFS Ecosystem
  • Company Profiles
Back to Top